Advances in Neuroblastoma Research, Vol. 3

GENETICS I. Is There a Neuroblastoma Anti-Oncogene? (M. Schwab). GENETICS II. Chromosome I Interphase-Cytogenetics in 32 Primary Neuroblastomas of Different Clinical Stages (H. Christiansen, et al.). DIFFERENTIATION I--RETINOIC ACID. Modulation of Protein Expression Associated with Chemically Induced Differentiation of Neuroblastoma Cells (N. Ikegaki, et al.). DIFFERENTIATION II--GROWTH FACTORS AND RECEPTORS. Multiple Defects of the Nerve Growth Factor Receptor in Human Neuroblastoma (C. Azar, et al.). DIFFERENTIATION III--EXPRESSION. Further Studies on the Interaction Between Vasoactive Intestinal Peptide and Neuroblastoma Cell Lines (J. Pence & N. Shorter). BIOLOGY AND THERAPY. The Interferon Induced 2-5A System in Neuroblastoma (G. Bruchelt, et al.). THERAPY I--MIBG. Differential Penetration of Targeting Agents Into Multicellular Spheroids Derived from Human Neuroblastoma (R. Mairs, et al.). THERAPY II--BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY. Stage IV Neuroblastoma More Than 1 Year of Age at Diagnosis: Major Response to Chemotherapy and Survival Durations Correlated Strongly with Dose Intensity (N. Cheung, et al.). SCREENING. Evaluation of a Rapid and Reliable Method for Mass Screening for Neuroblastoma in Infants (F. Schilling, et al.). Index.Evans, Audrey E. is the author of 'Advances in Neuroblastoma Research, Vol. 3', published 1991 under ISBN 9780471560852 and ISBN 0471560855.